Mortality due to bleeding · women with complete placenta praevia and intractable bleeding following caesarean section
1 finding from 1 review
Hysterectomy to control bleeding · women with complete placenta praevia and intractable bleeding following caesarean section
1 finding from 1 review
Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) · women with complete placenta praevia and intractable bleeding following caesarean section
1 finding from 1 review
Number of women with total blood loss 1000 mL or more after randomisation · women with complete placenta praevia and intractable bleeding following caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean blood loss (mL) (trialist defined) · women with complete placenta praevia and intractable bleeding following caesarean section
1 finding from 1 review
Blood transfusion (red cell or whole blood) · women with complete placenta praevia and intractable bleeding following caesarean section
It is very uncertain whether bakri balloon tamponade changes blood transfusion (red cell or whole blood) compared with haemostatic square suturing to the lower segment of the uterus… (very low certainty).
1 finding from 1 review
Side effects of the intervention (e.g. trauma, necrosis) · women with complete placenta praevia and intractable bleeding following caesarean section
1 finding from 1 review
Any cancer risk No. of participants: 19,475 (3 RCTs) · Participants in trials with low risk of bias
Highest showed no clear difference in any cancer risk No. of participants: 19,475 (3 RCTs) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Cancer mortality risk No. of participants: 17,448 (1 RCT) · Participants in trials with low risk of bias
Highest showed no clear difference in cancer mortality risk No. of participants: 17,448 (1 RCT) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Colorectal cancer risk (16 studies) · Participants in trials with low risk of bias
Highest showed no clear difference in colorectal cancer risk No. of participants: 19,009 (2 RCTs) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Non‐melanoma skin cancer risk No. of participants: 2027 (2 RCTs) · Participants in trials with low risk of bias
Highest showed no clear difference in non‐melanoma skin cancer risk No. of participants: 2027 (2 RCTs) compared with lowest selenium exposure (moderate certainty).
1 finding from 1 review
Lung cancer risk (17 studies) · Participants in trials with low risk of bias
Highest showed no clear difference in lung cancer risk No. of participants: 19,009 (2 RCTs) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Breast cancer risk (14 studies) · Participants in trials with low risk of bias
Highest showed no clear difference in breast cancer risk No. of participants: 802 (1 RCT) compared with lowest selenium exposure (moderate certainty).
1 finding from 1 review
Bladder cancer risk No. of participants: 19,009 (2 RCTs) · Participants in trials with low risk of bias
Highest showed no clear difference in bladder cancer risk No. of participants: 19,009 (2 RCTs) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Prostate cancer risk (13 studies) · Participants in trials with low risk of bias
Highest showed no clear difference in prostate cancer risk No. of participants: 18,942 (4 RCTs) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Perceived need for surgery in adulthood · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion)
The review found no eligible studies for this question.
1 finding from 1 review
Overjet · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion)
Bone-anchored intermaxillary traction (BAIMT) led to higher overjet compared with removable mandibular retractor (RMR); GRADE not reported.
1 finding from 1 review
Wits appraisal · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion)
Orthodontic removable traction appliance (ORTA) led to higher wits appraisal compared with untreated control (no treatment); GRADE not reported.
1 finding from 1 review
Wits appraisal · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion)
Facemask (with frame internal fixation) showed no clear difference in wits appraisal compared with frankel III functional appliance; GRADE not reported.
1 finding from 1 review
ANB · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion)
1 finding from 1 review
Arun 1994 (n=60): ANB data not usable (no SDs); Mann-Whitney P<0.001 benefit for mandibular headgear. Effect ~0.5 degrees, probably not clinically significant.
1 study · 60 participants
GRADE not reported